Literature DB >> 19692314

Overview of insulin delivery pen devices.

Lisa Kroon1.   

Abstract

OBJECTIVES: To review currently available insulin delivery pen devices for use in diabetes and to describe their primary benefits and drawbacks in comparison with the traditional vial/syringe method of insulin administration. DATA SOURCE: Not applicable.
SUMMARY: Insulin delivery pen devices are available for most types of insulin, including all insulin analog preparations and insulin premixes with rapid-acting insulin or regular insulin with neutral protamine Hagedorn insulin. Some devices have a replaceable insulin cartridge (categorized as reusable or durable); other devices are prefilled and are disposed of after the insulin reservoir is emptied. Insulin delivery pens offer several advantages over the vial and syringe method of injection, including greater ease and discretion of use and improved portability, adherence, and dosing accuracy. The tactile and auditory feedback provided by the dosing dial on insulin delivery pen devices may be particularly helpful for patients who have impaired manual dexterity or vision. Studies also show a strong preference among patients in favor of insulin delivery pen devices compared with the vial/syringe method. Finally, despite greater per-unit cost, insulin delivery pen devices have also been associated with reductions in health resource use and associated costs compared with vial/syringe therapy.
CONCLUSION: Insulin delivery pen devices offer another option to patients with diabetes for insulin administration. They are associated with not only improved ease of use but also improved dosing accuracy and adherence to therapy. To develop the most suitable insulin regimens for their patients, health providers should be informed about available insulin delivery pen devices.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692314     DOI: 10.1331/JAPhA.2009.08125

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  6 in total

Review 1.  Half-Unit Insulin Pens: Disease Management in Patients With Diabetes Who Are Sensitive to Insulin.

Authors:  David C Klonoff; Irina Nayberg; Udo Stauder; Hamid Oualali; Catherine Domenger
Journal:  J Diabetes Sci Technol       Date:  2016-11-28

2.  Analysis: linking laboratory data to human factors and inclusion of persons with disabilities in diabetes technology research.

Authors:  Ann S Williams
Journal:  J Diabetes Sci Technol       Date:  2011-09-01

3.  Comparison of patient satisfaction with two different etanercept delivery systems. A randomised controlled study in patients with rheumatoid arthritis.

Authors:  U Müller-Ladner; R M Flipo; P Vincendon; Y Brault; D Kielar
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

4.  A review of insulin pen devices and use in the elderly diabetic population.

Authors:  Bradley M Wright; Jessica M Bellone; Emily K McCoy
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2010-11-22

5.  Comparison of the Pharmacokinetics, Safety, and Tolerability of the Autoinjector (AI) and Pre-Filled Syringe (PFS) of SB4 in Healthy Subjects.

Authors:  Donghoon Shin; Younsoo Kim; Ahra Go; Maria Velinova
Journal:  Drug Des Devel Ther       Date:  2020-01-08       Impact factor: 4.162

6.  An evaluation of prefilled insulin pens: a focus on the Next Generation FlexPen(®).

Authors:  Estella M Davis; Emily L Sexson; Mikayla L Spangler; Pamela A Foral
Journal:  Med Devices (Auckl)       Date:  2010-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.